Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in East Setauket, NY
NPI: 1235174970Primary Practice Location
Stony Brook Ophthalmology
33 Research Way, East Setauket, NY
Primary Employer
Stony Brook Ophthalmology
stonybrookmedicine.edu
HQ Phone
Get M.D. Patrick's Phone NumberMobile
Get M.D. Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Tufts Medical Center
Internship • Internal Medicine
1977 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 48 | 59 |
| 2 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 22 | 22 |
| 3 | 92083Measurement of field of vision during daylight conditions | 22 | 24 |
Authors: Behrens, Christopher Maximilian, Malmqvist, Lasse, Jørgensen, Morten, Sibony, Patrick A, Munch, Inger Christine, Skovgaard, Anne Mette, Larsen, Michael, Hamann, Steffen
Journal: Am J Ophthalmol
Publication Date: 2022-09-13
Retinal and Choroidal Folds in Papilledema.
Authors: Sibony, Patrick A, Kupersmith, Mark J, Feldon, Steven E, Wang, Jui-Kai, Garvin, Mona
Journal: Invest Ophthalmol Vis Sci
Author Response: Choroidal Folds in Astronauts.
Authors: Randy Kardon
Journal: Invest Ophthalmol Vis Sci
Lead Sponsor: Jaeb Center for Health Research
Collaborators: National Eye Institute (NEI), University of Iowa, Icahn School of Medicine at Mount Sinai
Intervention / Treatment: DRUG: Acetazolamide, PROCEDURE: Optic Nerve Sheath Fenestration, PROCEDURE: Ventriculoperitoneal CSF Shunting
Lead Sponsor: Quark Pharmaceuticals
Intervention / Treatment: DRUG: QPI-1007 Injection - 3.0 mg, OTHER: Sham Injection Procedure, DRUG: QPI-1007 Injection - 1.5 mg
